Hypertrophic Cardiomyopathy and Longevity in Cats: A Global Study

Winn Feline Foundation Podcasts on Feline Health

Please join Dr. Glenn Olah, the President of Winn Feline Foundation, as he interviews Dr. Philip Fox on June 26, 2014. Dr. Fox, DVM, DACVIM, DECVIM, ACVECC Vincent Astor Chair in Comparative Medicine at the Caspary Institute, Animal Medical Center, in New York City, was one of the speakers at the 36th Annual Winn Symposium in New Orleans.

The interview will provide information regarding the most common heart disease found in cats, hypertrophic cardiomyopathy (HCM). The Foundation has been a leader in looking at the incidence, pathogenesis and potential treatments for feline heart disease, especially in the form of hypertrophic cardiomyopathy. Dr. Philip Fox’s research through the Animal Medical Center has lead to a international collaborative study that has identified risk factors for heart failure and survival in normal healthy cats and cats with HCM and will discuss the impact on feline health of heart disease, renal failure, and cancer. This is an extensive study in cats and will offer a large amount of information about cat health over a range of organ systems in addition to the heart-related implications.